Eventide Asset Management’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,080,605
| Closed | -$33.5M | – | 221 |
|
|
2024
Q4 | $33.5M | Sell |
4,080,605
-1,722,077
| -30% | -$14.2M | 0.61% | 51 |
|
|
2024
Q3 | $51.7M | Hold |
5,802,682
| – | – | 0.89% | 40 |
|
|
2024
Q2 | $43.9M | Hold |
5,802,682
| – | – | 0.75% | 45 |
|
|
2024
Q1 | $45.6M | Hold |
5,802,682
| – | – | 0.71% | 51 |
|
|
2023
Q4 | $51.4M | Buy |
5,802,682
+2,777,777
| +92% | +$24.6M | 0.84% | 43 |
|
|
2023
Q3 | $27.1M | Buy |
3,024,905
+89,386
| +3% | +$802K | 0.49% | 60 |
|
|
2023
Q2 | $36.3M | Buy |
2,935,519
+409,689
| +16% | +$5.06M | 0.61% | 51 |
|
|
2023
Q1 | $23.4M | Buy |
2,525,830
+274,462
| +12% | +$2.55M | 0.43% | 72 |
|
|
2022
Q4 | $23.6M | Buy |
+2,251,368
| New | +$23.6M | 0.47% | 70 |
|